相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sleep Moderates the Relationship Between Stress and Craving in Individuals With Opioid Use Disorder
Jenni B. Teeters et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2021)
The relationship between sleep and opioids in chronic pain patients
Amy Frers et al.
JOURNAL OF BEHAVIORAL MEDICINE (2021)
Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
Stacie Hudgens et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2021)
Orexin as a modulator of fear-related behavior: Hypothalamic control of noradrenaline circuit
Shingo Soya et al.
BRAIN RESEARCH (2020)
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
Yves Dauvilliers et al.
ANNALS OF NEUROLOGY (2020)
Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder
Gary Zammit et al.
NEUROLOGY (2020)
Evolution of Orexin Neuropeptide System: Structure and Function
Shingo Soya et al.
FRONTIERS IN NEUROSCIENCE (2020)
Sleep Quality and Sleep Disturbance Perception in Dual Disorder Patients
Gianina Luca et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders
Christoph Boss et al.
CHEMMEDCHEM (2020)
Sleep quality among individuals with ketamine use and the mediating role of craving
Cheng-Fang Yen et al.
SCIENTIFIC REPORTS (2020)
Abnormal Sleep Spindles, Memory Consolidation, and Schizophrenia
Dara S. Manoach et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 15 (2019)
An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
Fabrizio Schifano et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update
Sue Wilson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
A rodent cage change insomnia model disrupts memory consolidation
James T. McKenna et al.
JOURNAL OF SLEEP RESEARCH (2019)
Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies
Qian He et al.
JOURNAL OF CLINICAL NEUROLOGY (2019)
The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study
V. Tapiainen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Accelerated Development of the Dual Orexin Receptor Antagonist ACT-541468: Integration of a Microtracer in a First-in-Human Study
Clemens Muehlan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
Peter De Boer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin et al.
PHARMACOLOGICAL REVIEWS (2018)
Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of Chronoconnectivity
Idris A. Azeez et al.
FRONTIERS IN PHARMACOLOGY (2018)
The French addictovigilance network clinical assessment: Z-drugs, true false twins
Morgane Rousselet et al.
EXPERT OPINION ON DRUG SAFETY (2017)
The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
Alexander Treiber et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Neural Circuitry of Wakefulness and Sleep
Thomas E. Scammell et al.
NEURON (2017)
The roles of orexins in sleep/wake regulation
Michihiro Mieda
NEUROSCIENCE RESEARCH (2017)
Increased plasma orexin-A levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms
Shi Tang et al.
PEPTIDES (2017)
Role of Sleep Disturbance in the Trajectory of Alzheimer's Disease
Dong Woo Kang et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2017)
Increased Depression and Anxiety Symptoms are Associated with More Breakdowns in Cognitive Control to Cocaine Cues in Veterans with Cocaine Use Disorder
Gregory J. DiGirolamo et al.
JOURNAL OF DUAL DIAGNOSIS (2017)
Long-term benzodiazepine and Z-drugs use in the UK
James Davies et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2017)
Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension
Michael J. Huber et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems
Gregory S. Parks et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys
Pamela L. Tannenbaum et al.
SLEEP (2016)
Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys
Pamela L. Tannenbaum et al.
SLEEP (2016)
The Pathophysiology of Insomnia
Jessica C. Levenson et al.
CHEST (2015)
Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat
Daniele Viviani et al.
PSYCHOPHARMACOLOGY (2015)
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2014)
Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
Christoph Boss et al.
CHEMMEDCHEM (2014)
Trends in licit and illicit drug-related deaths in Florida from 2001 to 2012
Dayong Lee et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson et al.
LANCET NEUROLOGY (2014)
Benzodiazepine hypnotics, zolpidem and zopiclone on private prescriptions. Use between 1993 and 2012
F. Hoffmann et al.
NERVENARZT (2014)
Sleep and Substance Use Disorders: An Update
Deirdre A. Conroy et al.
CURRENT PSYCHIATRY REPORTS (2014)
The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
Stephen R. Morairty et al.
FRONTIERS IN NEUROSCIENCE (2014)
Predictive Factors for Relapse in Patients on Buprenorphine Maintenance
Michael Ferri et al.
AMERICAN JOURNAL ON ADDICTIONS (2014)
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2013)
Discovery and Characterization of ACT-335827, an Orally Available, Brain Penetrant Orexin Receptor Type1 Selective Antagonist
Michel A. Steiner et al.
CHEMMEDCHEM (2013)
The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat
Michel Alexander Steiner et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats
Aihua Li et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats
Steven V. Fox et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat
Michel A. Steiner et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
Jason M. Uslaner et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction
Ashley M. Blouin et al.
NATURE COMMUNICATIONS (2013)
In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving
Naren Gunja
JOURNAL OF MEDICAL TOXICOLOGY (2013)
Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
P. Hoever et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Acute Effects of Zolpidem Extended-Release on Cognitive Performance and Sleep in Healthy Males After Repeated Nightly Use
Bethea A. Kleykamp et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2012)
EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia
Jonas Lundahl et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Neurogenesis-Independent Antidepressant-Like Effects on Behavior and Stress Axis Response of a Dual Orexin Receptor Antagonist in a Rodent Model of Depression
Mathieu Nollet et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia
Paolo Bettica et al.
NEUROPSYCHOPHARMACOLOGY (2012)
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
Michel A. Steiner et al.
PSYCHOPHARMACOLOGY (2012)
Sleep Quality and 1-Year Incident Cognitive Impairment in Community-Dwelling Older Adults
Olivier Potvin et al.
SLEEP (2012)
Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey
Thomas Roth et al.
BIOLOGICAL PSYCHIATRY (2011)
Influence of Zolpidem and Sleep Inertia on Balance and Cognition During Nighttime Awakening: A Randomized Placebo-Controlled Trial
Danielle J. Frey et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression
Mathieu Nollet et al.
NEUROPHARMACOLOGY (2011)
The function of the sleep spindle: A physiological index of intelligence and a mechanism for sleep-dependent memory consolidation
Stuart M. Fogel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
...Not Just a Minor Thing, It Is Something Major, Which Stops You From Functioning Daily: Quality of Life and Daytime Functioning in Insomnia
Simon D. Kyle et al.
BEHAVIORAL SLEEP MEDICINE (2010)
Effect of once-daily almorexant treatment for 6 weeks on the sleep-wake cycle of normal Wistar rats
C. Brisbare-Roch et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
Hendrik Dietrich et al.
PSYCHOPHARMACOLOGY (2010)
The hyperarousal model of insomnia: A review of the concept and its evidence
Dieter Riemann et al.
SLEEP MEDICINE REVIEWS (2010)
Insomnia and health-related quality of life
Simon D. Kyle et al.
SLEEP MEDICINE REVIEWS (2010)
Comparative Tolerability of Newer Agents for Insomnia
Gary Zammit
DRUG SAFETY (2009)
Hypocretin /orexin contributes to the expression of some but not all forms of stress and arousal
Teri M. Furlong et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Jae-Eun Kang et al.
SCIENCE (2009)
Differential effects of diazepam treatment and withdrawal on recombinant GABAA receptor expression and functional coupling
Dubrauka Svob Strac et al.
BRAIN RESEARCH (2008)
Hypnosedative-Induced Complex Behaviours Incidence, Mechanisms and Management
Christian R. Dolder et al.
CNS DRUGS (2008)
Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time
Keith A. Wafford et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Catherine Brisbare-Roch et al.
NATURE MEDICINE (2007)
Insomnia: Pathophysiology and implications for treatment
Thomas Roth et al.
SLEEP MEDICINE REVIEWS (2007)
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Takeshi Sakurai
NATURE REVIEWS NEUROSCIENCE (2007)
GABAA receptor diversity and pharmacology
H. Moehler
CELL AND TISSUE RESEARCH (2006)
Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle
MG Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors
M Modirrousta et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Residual effects of hypnotics - Epidemiology and clinical implications
A Vermeeren
CNS DRUGS (2004)
Rotarod studies in the rat of the GABAA receptor agonist gaboxadol:: lack of ethanol potentiation and benzodiazepine cross-tolerance
J Voss et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone:: a review of case reports and epidemiological data
G Hajak et al.
ADDICTION (2003)
Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects
RM Salomon et al.
BIOLOGICAL PSYCHIATRY (2003)
Orexins activate histaminergic neurons via the orexin 2 receptor
A Yamanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Subjective sleep problems in later life as predictors of cognitive decline. Report from the Maastricht Ageing Study (MAAS)
M Jelicic et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2002)
Zolpidem use and hip fractures in older people
PS Wang et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)
Differential expression of orexin receptors 1 and 2 in the rat brain
JN Marcus et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)
Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons
NA Ator
DRUG AND ALCOHOL DEPENDENCE (2000)
Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons
NA Ator et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Chronic hypnotic use: deadly risks, doubtful benefit
DF Kripke
SLEEP MEDICINE REVIEWS (2000)
分享论文
